TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Oncodesign
US Patent
Oncodesign
US Patent
Affinity DataIC50: <100nMAssay Description:The inhibition of LRRK2 kinase was assessed using LRRK2 recombinant protein in an in vitro peptide-based kinase assay.ProtocolA radiometric protein k...More data for this Ligand-Target Pair